n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Asthma in 5 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Excerpt | Relevance | Reference |
---|---|---|
" In this study, we examined the role of NO in lipopolysaccharide (LPS)-induced inflammation in an ovalbumin (OVA)-challenged mouse asthma model." | 3.81 | Nitric oxide suppresses LPS-induced inflammation in a mouse asthma model by attenuating the interaction of IKK and Hsp90. ( Chiang, CP; Huang, CF; Lee, MY; Liu, HY; Sun, GH; Sun, KH; Tang, SJ; Tsou, YC, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Prado, CM | 1 |
Yano, L | 1 |
Rocha, G | 1 |
Starling, CM | 1 |
Capelozzi, VL | 1 |
Leick-Maldonado, EA | 1 |
Martins, Mde A | 1 |
Tibério, IF | 1 |
Lee, MY | 1 |
Sun, KH | 1 |
Chiang, CP | 1 |
Huang, CF | 1 |
Sun, GH | 1 |
Tsou, YC | 1 |
Liu, HY | 1 |
Tang, SJ | 1 |
Shin, TS | 1 |
Lee, BJ | 1 |
Tae, YM | 1 |
Kim, YS | 1 |
Jeon, SG | 1 |
Gho, YS | 1 |
Choi, DC | 1 |
Kim, YK | 1 |
Que, LG | 1 |
Liu, L | 1 |
Yan, Y | 1 |
Whitehead, GS | 1 |
Gavett, SH | 1 |
Schwartz, DA | 1 |
Stamler, JS | 1 |
Komlósi, ZI | 1 |
Pozsonyi, E | 1 |
Tábi, T | 1 |
Szöko, E | 1 |
Nagy, A | 1 |
Bartos, B | 1 |
Kozma, GT | 1 |
Tamási, L | 1 |
Orosz, M | 1 |
Magyar, P | 1 |
Losonczy, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Methods to Identify and Treat Severe Asthma Patients Project 1: GSNOR Phenotyping and GSNO Challenge[NCT03926741] | Early Phase 1 | 60 participants (Anticipated) | Interventional | 2019-04-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Asthma
Article | Year |
---|---|
Effects of inducible nitric oxide synthase inhibition in bronchial vascular remodeling-induced by chronic allergic pulmonary inflammation.
Topics: Administration, Inhalation; Amidines; Animals; Asthma; Benzylamines; Blood Vessels; Bronchi; Collage | 2011 |
Nitric oxide suppresses LPS-induced inflammation in a mouse asthma model by attenuating the interaction of IKK and Hsp90.
Topics: Animals; Asthma; Cells, Cultured; Cytokines; Disease Models, Animal; Female; HSP90 Heat-Shock Protei | 2015 |
Role of inducible nitric oxide synthase on the development of virus-associated asthma exacerbation which is dependent on Th1 and Th17 cell responses.
Topics: Animals; Asthma; Imines; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide Synt | 2010 |
Protection from experimental asthma by an endogenous bronchodilator.
Topics: Adrenergic beta-Agonists; Alcohol Dehydrogenase; Allergens; Animals; Asthma; Bronchi; Bronchial Hype | 2005 |
Lipopolysaccharide exposure makes allergic airway inflammation and hyper-responsiveness less responsive to dexamethasone and inhibition of iNOS.
Topics: Animals; Asthma; Bronchial Hyperreactivity; Cytokines; Dexamethasone; Drug Resistance; Female; Gluco | 2006 |